These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 19945306)

  • 1. Significance of P-glycoprotein, p53, and survivin expression in renal cell carcinoma.
    Baytekin F; Tuna B; Mungan U; Aslan G; Yorukoglu K
    Urol Oncol; 2011; 29(5):502-7. PubMed ID: 19945306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Value of p53 as a prognostic marker in histologic subtypes of renal cell carcinoma: a systematic analysis of primary and metastatic tumor tissue.
    Zigeuner R; Ratschek M; Rehak P; Schips L; Langner C
    Urology; 2004 Apr; 63(4):651-5. PubMed ID: 15072872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of p53 and bcl-2 in primary locally confined renal cell carcinomas: no evidence for prognostic significance.
    Hofmockel G; Wittmann A; Dammrich J; Bassukas ID
    Anticancer Res; 1996; 16(6B):3807-11. PubMed ID: 9042262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of tenascin-C expression in clear cell renal cell carcinoma.
    Ohno Y; Izumi M; Yoshioka K; Ohori M; Yonou H; Tachibana M
    Oncol Rep; 2008 Sep; 20(3):511-6. PubMed ID: 18695899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significance of heat shock protein-27 expression in patients with renal cell carcinoma.
    Erkizan O; Kirkali G; Yörükoğlu K; Kirkali Z
    Urology; 2004 Sep; 64(3):474-8. PubMed ID: 15351573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. pT1 clear cell renal cell carcinoma: a study of the association between MIB-1 proliferative activity and pathologic features and cancer specific survival.
    Cheville JC; Zincke H; Lohse CM; Sebo TJ; Riehle D; Weaver AL; Blute ML
    Cancer; 2002 Apr; 94(8):2180-4. PubMed ID: 12001115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significance of nuclear grade and tumor size in Korean patients with chromophobe renal cell carcinoma: a comparison with conventional renal cell carcinoma.
    Ku JH; Moon KC; Kwak C; Kim HH
    Urol Oncol; 2011; 29(5):487-91. PubMed ID: 19767221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The expression of thrombospondin-1 and p53 in clear cell renal cell carcinoma: its relationship to angiogenesis, cell proliferation and cancer specific survival.
    Zubac DP; Bostad L; Kihl B; Seidal T; Wentzel-Larsen T; Haukaas SA
    J Urol; 2009 Nov; 182(5):2144-9. PubMed ID: 19758660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicopathologic and molecular correlations of necrosis in the primary tumor of patients with renal cell carcinoma.
    Lam JS; Shvarts O; Said JW; Pantuck AJ; Seligson DB; Aldridge ME; Bui MH; Liu X; Horvath S; Figlin RA; Belldegrun AS
    Cancer; 2005 Jun; 103(12):2517-25. PubMed ID: 15880379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of ploidy, MIB-1 proliferation marker, and p53 in renal cell carcinoma.
    Kramer BA; Gao X; Davis M; Hall M; Holzbeierlein J; Tawfik O
    J Am Coll Surg; 2005 Oct; 201(4):565-70. PubMed ID: 16183495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic evaluation of COX-2 expression in renal cell carcinoma.
    Kankuri-Tammilehto MK; Söderström KO; Pelliniemi TT; Vahlberg T; Pyrhönen SO; Salminen EK
    Anticancer Res; 2010 Jul; 30(7):3023-30. PubMed ID: 20683050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucose-regulated protein 78 positivity as a predictor of poor survival in patients with renal cell carcinoma.
    Kuroda K; Horiguchi A; Asano T; Ito K; Asakuma J; Sato A; Yoshii H; Hayakawa M; Sumitomo M; Asano T
    Urol Int; 2011; 87(4):450-6. PubMed ID: 22076227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of renal vein and inferior vena cava involvement in renal cell carcinoma.
    Wagner B; Patard JJ; Méjean A; Bensalah K; Verhoest G; Zigeuner R; Ficarra V; Tostain J; Mulders P; Chautard D; Descotes JL; de la Taille A; Salomon L; Prayer-Galetti T; Cindolo L; Valéri A; Meyer N; Jacqmin D; Lang H
    Eur Urol; 2009 Feb; 55(2):452-9. PubMed ID: 18692951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation between lymphangiogenesis and clinicopathological parameters in renal cell carcinoma.
    Ozardili I; Guldur ME; Ciftci H; Bitiren M; Altunkol A
    Singapore Med J; 2012 May; 53(5):332-5. PubMed ID: 22584974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apoptotic regulators: P53 and survivin expression in non-small cell lung cancer.
    Porebska I; Sobańska E; Kosacka M; Jankowska R
    Cancer Genomics Proteomics; 2010; 7(6):331-5. PubMed ID: 21156966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survivin expression is a negative prognostic marker in laryngeal squamous cell carcinoma and is associated with p53 accumulation.
    Pizem J; Cör A; Gale N
    Histopathology; 2004 Aug; 45(2):180-6. PubMed ID: 15279637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survivin expression in ovarian carcinoma: correlation with apoptotic markers and prognosis.
    Cohen C; Lohmann CM; Cotsonis G; Lawson D; Santoianni R
    Mod Pathol; 2003 Jun; 16(6):574-83. PubMed ID: 12808063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biologic significance of fascin expression in clear cell renal cell carcinoma: systematic analysis of primary and metastatic tumor tissues using a tissue microarray technique.
    Zigeuner R; Droschl N; Tauber V; Rehak P; Langner C
    Urology; 2006 Sep; 68(3):518-22. PubMed ID: 16979727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Expression of S100 protein in renal cell carcinoma and its relation with P53].
    Yang JF; Zhang XY; Qi F
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2004 Jun; 29(3):301-4. PubMed ID: 16136965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tissue microarray analysis of the prognostic value of E-cadherin, Ki67, p53, p27, survivin and MSH2 expression in upper urinary tract transitional cell carcinoma.
    Fromont G; Rouprêt M; Amira N; Sibony M; Vallancien G; Validire P; Cussenot O
    Eur Urol; 2005 Nov; 48(5):764-70. PubMed ID: 16126329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.